Stay updated on Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Sign up to get notified when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label changed from v3.5.3 to v3.5.4, indicating a new build or update. No study content or data appears to be changed by this update.
    Difference
    0.0%
    Check dated 2026-05-15T04:14:06.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision tag (v3.5.3) replaces the previous tag (v3.5.2), signaling an update to the page's version.
    Difference
    0.0%
    Check dated 2026-04-30T17:41:50.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T10:45:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T15:41:35.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a site version update with no changes to study data or participant information.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:47.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed Revision: v3.4.1 and the lapse in government funding notice.
    Difference
    0.4%
    Check dated 2026-02-11T02:05:10.000Z thumbnail image

Stay in the know with updates to Phase II Anti-PD1 Epigenetic Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Anti-PD1 Epigenetic Therapy Clinical Trial page.